scholarly article | Q13442814 |
systematic review | Q1504425 |
review article | Q7318358 |
P50 | author | Carol Aghajanian | Q91946596 |
Glynnis McDonnell | Q38326053 | ||
Shira Hichenberg | Q47249015 | ||
P2093 | author name string | Isabel Sulimanoff | |
Melissa Ozga | |||
Sabrina Jhanwar | |||
Shannon Myers-Virtue | |||
P2860 | cites work | Perspectives on living with ovarian cancer: young women's views | Q77764757 |
Cancer statistics, 2014 | Q27861018 | ||
Psychological aspects of ovarian cancer | Q33659826 | ||
Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials | Q33947886 | ||
Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence | Q34036483 | ||
Psychological well being and quality of life in ovarian cancer survivors | Q35207277 | ||
The silent killer: psychological issues in ovarian cancer | Q35598175 | ||
Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients | Q35691922 | ||
The AFTER intervention: a structured psychological approach to reduce fears of recurrence in patients with head and neck cancer | Q37168688 | ||
Fear of cancer recurrence: a systematic literature review of self-report measures | Q37948703 | ||
Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies | Q37974605 | ||
Factors reported to influence fear of recurrence in cancer patients: a systematic review | Q38016837 | ||
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies | Q38087904 | ||
Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study | Q39264716 | ||
Women's experiences following treatment for gynecologic cancer. | Q39456460 | ||
Identifying supportive care needs of women with ovarian cancer | Q39860905 | ||
Sword of Damocles cutting through the life stages of women with ovarian cancer | Q39947996 | ||
Transforming the death sentence: elements of hope in women with advanced ovarian cancer | Q40152778 | ||
Coping and communication-enhancing intervention versus supportive counseling for women diagnosed with gynecological cancers | Q40188385 | ||
Adult cancer survivors: how are they faring? | Q40376507 | ||
The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence | Q40605623 | ||
Fear of cancer recurrence--a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears | Q40892922 | ||
Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease | Q43954617 | ||
Comparison of the quality of life of early and advanced stage ovarian cancer survivors | Q47335421 | ||
Canadian women's perspectives on ovarian cancer | Q48745440 | ||
Evaluation of two group therapies to reduce fear of progression in cancer patients | Q48967904 | ||
Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. | Q50681587 | ||
Supportive expressive group therapy for women with advanced ovarian cancer. | Q50683635 | ||
Nurse led telephone follow up in ovarian cancer: a psychosocial perspective. | Q50773775 | ||
The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer. | Q50954476 | ||
The views of ovarian cancer survivors on its cause, prevention, and recurrence. | Q51061222 | ||
Mastectomy patients and the fear of cancer recurrence. | Q51256595 | ||
Long-term adjustment of early-stage ovarian cancer survivors. | Q51894628 | ||
Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
Women’s Experiences With Recurrent Ovarian Cancer | Q61713018 | ||
Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress | Q73872723 | ||
Perspectives on living with ovarian cancer: older women's views | Q77083647 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
systematic review | Q1504425 | ||
P304 | page(s) | 1771-1780 | |
P577 | publication date | 2015-03-02 | |
P1433 | published in | Palliative and Supportive Care | Q15758536 |
P1476 | title | A systematic review of ovarian cancer and fear of recurrence | |
P478 | volume | 13 |
Q89908224 | A Study on the Psychological Factors Affecting the Quality of Life Among Ovarian Cancer Patients in China |
Q47291982 | Anxiety and Depression in Cancer Survivors |
Q92286902 | Assessment of Unmet Supportive Care Needs in Haematological Cancer Survivors |
Q47679295 | Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer. |
Q92598066 | Chinese Version of the Assessment of Survivor Concerns Scale for Gynecological Cancer Survivors: A Psychometric Study in Taiwan |
Q92293397 | Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer |
Q92320251 | Dexmedetomidine Regulates Proliferation, Apoptosis, Migration, and Invasion in Ovarian Cancer Cells via MiR-155-HIF-1α Axis |
Q42644504 | Effect of different anesthetic methods on cellular immune functioning and the prognosis of patients with ovarian cancer undergoing oophorectomy |
Q55313752 | Experience and Expectations of Ovarian Cancer Patients in Australia. |
Q40875743 | Fear of cancer recurrence in prostate cancer survivors. |
Q64994384 | Fear of cancer recurrence: A study of the experience of survivors of ovarian cancer. |
Q37367890 | Follow-up of patients who are clinically disease-free after primary treatment for fallopian tube, primary peritoneal, or epithelial ovarian cancer: a Program in Evidence-Based Care guideline adaptation |
Q47941997 | Future Research in Psycho-Oncology |
Q92669172 | Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance |
Q58586232 | Nano-Mediated Photodynamic Therapy for Cancer: Enhancement of Cancer Specificity and Therapeutic Effects |
Q64981474 | Peur de la récidive: Étude de l’expérience vécue par les survivantes du cancer des ovaires. |
Q89389518 | Recent Progress in Gene Therapy for Ovarian Cancer |
Q47228933 | SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer |
Q92628962 | The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat |
Q47101331 | When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges. |
Search more.